STRANG, John,OKSCHE, Alexander,HARRIS, Stephen,SMITH, Kevin,MOTTIER, Lucie Helene Jeanne
申请号：
HUE12721507
公开号：
HUE036465T2
申请日:
2012.05.11
申请国别(地区):
HU
年份:
2018
代理人:
摘要：
The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ‰¥ 0.5 mg naloxone HCl dissolved in an application fluid of a volume of ‰¤ 250 µl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
